MarginsXMarginsX
Home › Markets › ISCO

International Stem Cell CORP (ISCO)

ISCO is quoted over the counter, not listed on an exchange. International Stem Cell CORP files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.1600
0.0% on the day
1-year return
0.0%
Market cap
$1.3M
Nano cap. From the Nov 13, 2026 close × 8M shares (10-Q cover page, Aug 11, 2026)
P/E and P/S
Net loss over the period · 0.1×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerISCO, quoted over the counter
SEC CIK0001355790
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressSan Diego, CA
Incorporated inDE

Warning signs

Cash runway
Cash-flow positive
$1.1M cash at June 30, 2026
Share count, 1 year
0.0%
2025-08-11 to 2026-08-11 · 0.0% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
-$10K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Based on the factors above, there is substantial doubt about our ability to continue as a going concern."
10-Q 2026-08-13
Cash and burn$1.1M cash; operating cash flow $92K a quarter.Report 2026-06-30
Shares outstanding8,004,389 (2026-08-11); 8,004,389 a year earlier; 8,004,389 three years earlier.Cover page 2026-08-11
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO USA, P.C., San Diego, California, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $10K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$2.7M-$71K$167K$1.1M$3.3M$9.5M10-Q 2026-08-13
Q1 2026
2026-03-31
$2.3M-$220K$121K$933K$3.2M$9.3M10-Q 2026-05-14
Q4 2025
2025-12-31
$2.2M-$348K$32K$993K$3.3M$9.1M10-K 2026-03-30
Q3 2025
2025-09-30
$2.4M$57K$49K$966K$3.3M$9.4M10-Q 2025-11-13
Q2 2025
2025-06-30
$2.4M$129K-$300K$920K$3.3M$9.2M10-Q 2026-08-13
Q1 2025
2025-03-31
$2.1M-$256K$227K$1.5M$3.4M$9.1M10-Q 2026-05-14
Q4 2024
2024-12-31
$2.4M$11K-$74K$1.2M$3.4M$9.1M10-K 2026-03-30
Q3 2024
2024-09-30
$2.2M-$125K$257K$1.3M$3.4M$8.5M10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2017-06-09
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-08-13
Latest current report8-K2026-09-08
Latest proxyDEF 14A2026-04-29

Source: SEC EDGAR submissions feed, 825 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier